OIS San Diego

MAY 2, 2019
SAN DIEGO, CA

OIS unites over 500 industry, entrepreneurial and clinical leaders to collaborate on the development and commercialization of innovative drugs and devices to address unmet clinical needs.

OIS@ASCRS
OIS Chicago

JULY 25, 2019
CHICAGO, IL

OIS unites 300 industry, entrepreneurial and clinical leaders to collaborate on the development and commercialization of innovative drugs and devices to address unmet clinical needs.

OIS@ASRS 2019
OIS San Francisco

OCTOBER 10, 2019
SAN FRANCISCO, CA

OIS unites over 1,000 industry, entrepreneurial and clinical leaders to collaborate on the development and commercialization of innovative drugs and devices to address unmet clinical needs.

OIS@AAO

The Ophthalmology Innovation Summits facilitate meaningful interactions and the exchange of information between clinical, capital and corporate leaders to accelerate the development and commercialization of novel therapies to address unmet needs.

LATEST NEWS

Keeping an "Eye on Innovation" Through News & Analysis

Will a New Drug Using Cannabinoids Achieve a Breakthrough for Glaucoma?

Will a New Drug Using Cannabinoids Achieve a Breakthrough for Glaucoma?

SAN FRANCISCO – Nemus Bioscience, a biopharmaceutical company based in Southern California, came to the Glaucoma 360 New Horizons Forum here in February to make ...
Biogen Jumps Back into Ophthalmology Gene Therapy with Nightstar Acquisition

Biogen Jumps Back into Ophthalmology Gene Therapy with Nightstar Acquisition

It didn’t take Biogen long to jump back into ophthalmology after announcing its intention in December 2018 to terminate a collaborative agreement with Applied Genetic ...
Larry Haimovitch, 72, of Mill Valley, California

Larry Haimovitch, 72, Journalist, Advisor and Ophthalmology Leader

Larry Haimovitch, 72, Journalist, Advisor and Ophthalmology Leader Larry Haimovitch, 72, husband of Carie Harris Haimovitch, of Mill Valley, California, died peacefully at home February ...
How Glaucoma Device Companies Raise Funding to Navigate ‘Death Valley’

How Glaucoma Device Companies Raise Funding to Navigate ‘Death Valley’

SAN FRANCISCO – At the Glaucoma 360 New Horizons Forum here, Emmett Cunningham, Jr., MD, PhD, moderating a panel on financing for emerging glaucoma device ...
The Upside of the Optometric Channel

Corporate Leaders Explain the Upside of the Optometric Channel

NEW ORLEANS – Optometry has become a source of big business for ophthalmic companies over the past decade, with about 40 to 60% of sales ...
10 Takeaways from Roche-Spark Deal

10 Takeaways from Roche’s $4.8 Billion Offer to Acquire Spark Therapeutics

Here are 10 things to know about Roche’s $4.8 billion bid to acquire Spark Therapeutics. Roche’s $114.5-a-share offer is a 122% premium over the closing ...

STAY UP TO DATE WITH OIS

Get the Latest News, Podcasts and Videos.